Sandy Ferber

A Phase II Study of Depsipeptide in Refractory Metastatic Renal Cell Cancer

Walter M. Stadler, Kim Margolin, Sandy Ferber et al. · Clinical Genitourinary Cancer · 2006 · 153 citations

Medicine, Oncology, Pharmacology +11

Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study

Elliot Offman, Ted Marenco, Sandy Ferber et al. · Vascular Health and Risk Management · 2013 · 91 citations · Full text

Pharmacy, Nutritional Sciences, Pharmacokinetics +14

Results from a phase 2b, randomized, multicenter study of GVAX pancreas and CRS-207 compared to chemotherapy in adults with previously-treated metastatic pancreatic adenocarcinoma (ECLIPSE Study).

Dung T. Le, Andrew H. Ko, Zev A. Wainberg et al. · Journal of Clinical Oncology · 2017 · 45 citations

Medicine, Oncology, Pharmacology +17

Phase II, randomized study of GVAX pancreas and CRS-207 immunotherapy in patients with metastatic pancreatic cancer: Clinical update on long term survival and biomarker correlates to overall survival.

Chan C. Whiting, Eric R. Lutz, Nitya Nair et al. · Journal of Clinical Oncology · 2015 · 13 citations

Medicine, Immunology, Oncology +17

Randomized phase II study of the safety, efficacy, and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR).

Dung T. Le, Todd S. Crocenzi, Jennifer N. Uram et al. · Journal of Clinical Oncology · 2016 · 13 citations

Life Sciences, Immunology, Pharmacology +17